PortfoliosLab logo
TECH vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TECH and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

TECH vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bio-Techne Corporation (TECH) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

TECH:

-0.91

PFE:

-0.63

Sortino Ratio

TECH:

-1.31

PFE:

-0.54

Omega Ratio

TECH:

0.84

PFE:

0.94

Calmar Ratio

TECH:

-0.59

PFE:

-0.20

Martin Ratio

TECH:

-1.89

PFE:

-0.81

Ulcer Index

TECH:

20.02%

PFE:

14.43%

Daily Std Dev

TECH:

40.46%

PFE:

24.08%

Max Drawdown

TECH:

-74.39%

PFE:

-58.96%

Current Drawdown

TECH:

-63.21%

PFE:

-54.77%

Fundamentals

Market Cap

TECH:

$7.62B

PFE:

$133.38B

EPS

TECH:

$0.83

PFE:

$1.38

PE Ratio

TECH:

58.57

PFE:

17.00

PEG Ratio

TECH:

1.33

PFE:

0.60

PS Ratio

TECH:

6.30

PFE:

2.14

PB Ratio

TECH:

3.78

PFE:

1.48

Total Revenue (TTM)

TECH:

$1.21B

PFE:

$62.46B

Gross Profit (TTM)

TECH:

$796.33M

PFE:

$42.09B

EBITDA (TTM)

TECH:

$284.25M

PFE:

$17.24B

Returns By Period

In the year-to-date period, TECH achieves a -32.32% return, which is significantly lower than PFE's -8.82% return. Over the past 10 years, TECH has outperformed PFE with an annualized return of 7.79%, while PFE has yielded a comparatively lower 0.87% annualized return.


TECH

YTD

-32.32%

1M

-3.57%

6M

-35.88%

1Y

-36.71%

3Y*

-18.33%

5Y*

-5.15%

10Y*

7.79%

PFE

YTD

-8.82%

1M

-1.67%

6M

-5.36%

1Y

-15.01%

3Y*

-19.97%

5Y*

-2.98%

10Y*

0.87%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Bio-Techne Corporation

Pfizer Inc.

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

TECH vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TECH
The Risk-Adjusted Performance Rank of TECH is 77
Overall Rank
The Sharpe Ratio Rank of TECH is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of TECH is 77
Sortino Ratio Rank
The Omega Ratio Rank of TECH is 99
Omega Ratio Rank
The Calmar Ratio Rank of TECH is 1313
Calmar Ratio Rank
The Martin Ratio Rank of TECH is 11
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 2626
Overall Rank
The Sharpe Ratio Rank of PFE is 1717
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 2121
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 2323
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 3737
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 3232
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TECH vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bio-Techne Corporation (TECH) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current TECH Sharpe Ratio is -0.91, which is lower than the PFE Sharpe Ratio of -0.63. The chart below compares the historical Sharpe Ratios of TECH and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

TECH vs. PFE - Dividend Comparison

TECH's dividend yield for the trailing twelve months is around 0.66%, less than PFE's 7.28% yield.


TTM20242023202220212020201920182017201620152014
TECH
Bio-Techne Corporation
0.66%0.44%0.41%0.77%0.25%0.40%0.58%0.88%0.99%1.24%1.42%1.35%
PFE
Pfizer Inc.
7.28%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%3.34%

Drawdowns

TECH vs. PFE - Drawdown Comparison

The maximum TECH drawdown since its inception was -74.39%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for TECH and PFE.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

TECH vs. PFE - Volatility Comparison

Bio-Techne Corporation (TECH) has a higher volatility of 15.50% compared to Pfizer Inc. (PFE) at 8.90%. This indicates that TECH's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

TECH vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Bio-Techne Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B25.00B20212022202320242025
316.18M
13.72B
(TECH) Total Revenue
(PFE) Total Revenue
Values in USD except per share items

TECH vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between Bio-Techne Corporation and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
67.9%
79.3%
(TECH) Gross Margin
(PFE) Gross Margin
TECH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Bio-Techne Corporation reported a gross profit of 214.56M and revenue of 316.18M. Therefore, the gross margin over that period was 67.9%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.

TECH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Bio-Techne Corporation reported an operating income of 38.71M and revenue of 316.18M, resulting in an operating margin of 12.2%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Pfizer Inc. reported an operating income of 4.43B and revenue of 13.72B, resulting in an operating margin of 32.3%.

TECH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Bio-Techne Corporation reported a net income of 22.59M and revenue of 316.18M, resulting in a net margin of 7.1%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.